VIVO (9002)
Catheter Precision, Inc. · Decision date Oct 30, 2026
What did the FDA decide?
The FDA recorded a substantially equivalent (SESE) decision for VIVO (9002), submitted by Catheter Precision, Inc. of Fort Mill, South Carolina, under 510(k) number K261886. The application was received on 06/05/2026 and decided on 10/30/2026. The device falls under regulation 870.1425 with classification product code DQK, device classification name "Computer, Diagnostic, Programmable," and the cardiovascular medical specialty and review panel.
A SESE decision means the FDA cleared the submission as substantially equivalent to a legally marketed predicate device; it is not a premarket approval. The public record identifies the applicant contact as Darci Diage and notes the summary type as Special, with no third-party review, no combination product designation, and no authorized predetermined change control plan. The record does not describe the specific components, software changes, or indications for use, so the scope of what was cleared remains unknown from this page.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 30, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261886
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Catheter Precision, Inc.
- Product code
- DQK
- Decision code
- SESE
- Decision date
- Oct 30, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Computer, Diagnostic, Programmable.
- Applicant
- Catheter Precision, Inc.
- Product code
- DQK
- FDA device class
- 2
FDA decision timeline
K261886 received
Application receipt date recorded by FDA.
K261886 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code DQK
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Merge Healthcare Incorporated | 510(k) clearance | Nov 5, 2026 | FDA | |
PulseAPI SmartWatchK254226 | PulseAI, Ltd. | 510(k) clearance | Oct 27, 2026 | FDA |
STAR Apollo Mapping SystemK263380 | Rhythm AI, Ltd. | 510(k) clearance | Oct 23, 2026 | FDA |
| Centerline Biomedical | 510(k) clearance | Oct 1, 2026 | FDA | |
S-Patch CardioAIK254255 | Wellysis Corp. | 510(k) clearance | Sep 25, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Catheter Precision, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Fort Mill, SC
Sources and methodology
- Original FDA record: K261886
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


